Chinese Humanoid Robot Companies (2026)
In January 2026, research firm Omdia released its first global ranking of humanoid robot shipments. The top three names were all Chinese. According to Forbes, 87% of all humanoid robots delivered in 2025 were made in China, primarily by just two companies: AgiBot and Unitree.
This is not widely understood in the West. Most English-language tech coverage focuses on Tesla Optimus, Figure AI, and Boston Dynamics. These are important companies, but they are not where the majority of actual shipments come from. China dominates humanoid manufacturing today, backed by government policy, massive venture capital, and a manufacturing ecosystem centered around Shenzhen that can iterate hardware faster than anywhere else.
This guide profiles the major Chinese humanoid robot companies, what they make, what they cost, and where they are deployed.
The landscape at a glance
| Company | Founded | Total Funding | Key Product | Est. Shipments (2025) | Status |
|---|---|---|---|---|---|
| AgiBot | 2023 | ~$1B+ | Multiple models | ~5,168 (Omdia estimate) | Company/analyst-reported shipments; product-specific status varies |
| Unitree | 2016 | $246M+ | G1, H2 | ~5,500 (reported estimate) | Direct ordering; Unitree calls G1 a mass-production version |
| XPENG Robotics | — (XPENG robotics unit) | $900M robotics round | IRON | Not disclosed | Production line commissioned; pre-mass-production |
| Galbot | 2023 | ~$700M+ | Galbot series | Unknown | Company-reported deployments; manufacturing and broad shipping unconfirmed |
| UBTech | 2012 | $940M+ (IPO) | Walker S2, UWORLD U1 | 1,000-unit-level Walker S2 production/delivery (company-reported) | Small-scale mass production and delivery |
| Fourier Intelligence | 2015 | $100M+ | GR-2 | Unknown | Contact sales; production volume and shipping unconfirmed |
| LimX Dynamics | 2022 | Unknown | CL-1, CL-2 | Unknown | Development platforms; broad commercial shipping unconfirmed |
Important caveat: shipment numbers in this industry are disputed and often unverified. AgiBot and Unitree both claim top positions depending on counting methodology (per Omdia’s January 2026 report). “Shipped,” “mass-produced” and “deployed” are not interchangeable: a delivered research unit, a customer pilot and a robot performing sustained autonomous work represent different maturity signals.
AgiBot (智元机器人)
Founded: 2023 (Shanghai) Funding: Over $1 billion (estimated from multiple rounds, exact total not publicly confirmed) Key fact: Estimated market leader by shipments alongside Unitree
AgiBot is remarkable for its speed. Founded in 2023, it reached the top of global humanoid shipment rankings by early 2026, condensing years of typical startup growth into months. The company makes multiple humanoid models for different industrial applications.
Forbes reported that “Galbot and Agibot, both founded in 2023, have already raised a combined total of nearly $2 billion.” This funding velocity reflects how seriously Chinese investors and government policy take humanoid robotics.
AgiBot was reported to have dropped its U.S. launch of three models, suggesting geopolitical and market-access considerations are already affecting the industry.
What they ship: Industrial humanoids for manufacturing and logistics Where they deploy: Chinese factories and warehouses primarily Western coverage gap: AgiBot is rarely mentioned in mainstream English-language tech publications despite being the global shipment leader
Unitree (宇树科技)
Founded: 2016 (Hangzhou) Funding: $246M+ total Key products: G1 ($13,500), H2 ($29,900) IPO status: Rushing to list per CNBC (July 2026)
Unitree is the most visible Chinese humanoid company in the West, primarily because of their aggressive pricing and direct-to-buyer sales model. Their robots are orderable internationally through their website and through resellers like Robozaps.
Unlike many competitors that sell primarily to Chinese industry, Unitree has cultivated a global developer community. Their G1 is the de facto standard research humanoid in universities worldwide because of its $13,500 price point.
Unitree is also notable for its earlier quadruped (dog-like) robots, which established the company’s manufacturing expertise before pivoting to humanoids.
Strengths: Lowest prices, international availability, growing developer community, IPO-track validates business model Limitations: Q1 2026 profit fell by half despite growing shipments (per Technology.org), suggesting aggressive pricing is eating into margins
For a detailed comparison with Western competitors, see our Unitree vs Figure vs Tesla Optimus article.
For a Unitree-centered case study of this market, see Unitree’s role in China’s humanoid robot ecosystem.
XPENG Robotics (小鹏机器人)
Parent company: XPENG (Guangzhou) Key product: IRON humanoid Manufacturing maturity: Production line commissioned; pre-mass-production Source checked: September 8, 2026
XPENG commissioned its humanoid production lines and reported that an IRON unit completed the line process and walked off the line. XPENG also says more than 80% of core production processes are automated. These are company-reported manufacturing milestones, not independent evidence of output volume, yield, or customer deliveries.
Confirmed now: The production line is operational and at least one IRON has completed it. This moves IRON beyond a prototype-only status into production-line manufacturing.
Announced next: XPENG targets mass production by the end of 2026, initial use in its own stores and campuses, and market launch and deliveries in China and overseas in 2027. Those steps remain plans. IRON is not yet generally available or commercially shipping.
For the same status in the global market context, see the humanoid manufacturers by country directory.
Galbot (星尘智能)
Founded: 2023 (Shenzhen) Funding: ~$700M+ (including a 2.5 billion yuan round in March 2026) Key fact: Highest-valued unlisted humanoid robotics firm in China
Galbot’s March 2026 funding round was notable for including China’s national AI industry investment fund, China Petroleum & Chemical Corp (Sinopec), and CITIC Investment Holdings. Galbot reports robots operating in retail, industrial, logistics, medical and service settings, but does not disclose enough production and customer-delivery detail to verify broad commercial shipping.
The company focuses on embodied intelligence, combining physical hardware with AI that learns from interaction. Their funding trajectory ($700M+ raised in under 3 years from founding) is extraordinary even by Chinese venture capital standards.
What they ship: Embodied intelligent robots for industrial and commercial applications Western coverage gap: Almost no English-language coverage despite being the highest-funded Chinese humanoid startup. The AI Insider and Global Times are among the few English sources covering their funding rounds.
UBTech (优必选)
Founded: 2012 (Shenzhen) Funding: $940M+ pre-IPO, then Hong Kong IPO (December 2023) Key products: Walker series, UWORLD U1 IPO status: Publicly traded on HKEX
UBTech is the most established Chinese humanoid company, having been in the space since 2012. They are publicly traded (the first humanoid robot company to IPO globally) and have the longest track record.
UBTECH’s strongest production evidence concerns Walker S2. Its 2025 annual report says the model reached “1,000-unit-level small-scale mass production and delivery.” That company disclosure is stronger than a planned capacity claim, but it should not be generalized to every Walker or UWORLD model. UBTECH separately markets UWORLD U1 as mass-produced; the product-specific output and delivery evidence remains less detailed.
Strengths: Longest track record, publicly traded (financial reporting), diverse product line, company-reported Walker S2 production and delivery Limitations: Older company with more conservative innovation pace than AgiBot/Galbot
Fourier Intelligence (傅利叶智能)
Founded: 2015 (Shanghai) Key product: GR-2 general-purpose humanoid Background: Originally a rehabilitation robotics company, pivoted to general-purpose humanoids
Fourier Intelligence brings a unique background: they started in medical rehabilitation robots (exoskeletons and therapy devices), giving them deep expertise in precise human-like motion and safety around people. Their GR-2 humanoid leverages this rehabilitation background for smooth, human-safe movement.
Strengths: Safety expertise from medical robotics background, human-like motion quality, diverse application targets (healthcare + general purpose) Limitations: Less venture funding than AgiBot/Galbot; current GR-2 production volume and customer-shipping scope are not publicly disclosed
LimX Dynamics (逐际动力)
Founded: 2022 (Shenzhen) Status: Rushing to IPO per CNBC (July 2026) Focus: Dynamic locomotion and whole-body control
LimX is the newest entrant but already attracting attention for their locomotion capabilities. CNBC reported in July 2026 that they are among Chinese humanoid startups rushing to list, alongside Unitree.
Their focus is more narrowly on locomotion and dynamics (making robots walk, run, and balance well) rather than full-stack humanoid intelligence. This specialization may make them an attractive component provider or acquisition target.
The funding landscape
Chinese humanoid robotics funding is in a class of its own:
- Total sector: $9.8 billion cumulative VC funding by end of 2025
- Growth: 2026 Q1 funding up 288% year-over-year
- Market revenue: ~$4.89 billion in 2025, projected $6.24 billion in 2026
- Gap: Funding ($9.8B+) exceeds revenue ($4.89B) by roughly 2:1, suggesting the sector is still investment-driven rather than profit-driven
The funding-to-revenue gap means these companies are collectively spending more on development than they are earning from sales. This is sustainable only as long as investor confidence (and government policy support) holds. It creates risk for individual companies but accelerates the entire category’s development speed.
Government backing
China’s humanoid robotics push is not just market-driven. Government policy explicitly targets humanoid robots as a strategic technology:
- National-level AI funds are directly investing (Galbot’s March 2026 round)
- State-owned enterprises (Sinopec, CITIC) are anchor investors
- Production targets for humanoid deployment in manufacturing and logistics exist at both national and provincial levels
- Government procurement provides a guaranteed domestic market
This means Chinese humanoid companies operate with a funding floor that Western competitors (who rely purely on venture capital and commercial customers) do not have. Even if commercial demand is slower than expected, government support can bridge the gap.
Why this matters for the global industry
The Chinese dominance in actual humanoid shipments (87% globally per Forbes) creates several dynamics:
Price competition. Unitree’s $13,500 G1 sets a floor that Western companies must compete with. Figure and Tesla cannot price significantly above this without a compelling quality or capability justification.
Speed of iteration. Chinese companies iterate hardware faster because of the Shenzhen manufacturing ecosystem: rapid prototyping, cheap components, experienced factory labor. AgiBot went from founding to market leader in under 3 years.
Information asymmetry. Most of what these companies publish is in Chinese. Their WeChat announcements, technical papers, and product updates reach Chinese developers first and may never be translated. Following this space purely through English-language sources means missing significant developments.
Geopolitical risk. AgiBot dropping its U.S. launch signals that market access is not guaranteed. Export controls, tariffs, and geopolitical tensions could fragment the market into Chinese and Western ecosystems with limited interoperability.
How to follow Chinese robotics
If you want to stay current on this space:
- Omdia publishes quarterly humanoid shipment rankings
- CNBC covers the IPO and business side of Chinese humanoid startups
- Forbes (Edith Yeung) covers Chinese AI/robotics venture capital
- Global Times and Pandaily cover Chinese funding rounds in English
- WeChat accounts of individual companies (requires Chinese language)
- Physical AI Field (this site) will track Chinese robotics as a permanent coverage area
FAQ
Which Chinese company makes the most humanoid robots?
AgiBot and Unitree are both estimated at roughly 5,000-5,500 units shipped in 2025, making them the global leaders. The exact ranking is disputed depending on counting methodology.
Can I buy a Chinese humanoid robot outside China?
Unitree offers direct international ordering for selected models. UBTECH and Fourier use enterprise or contact-sales channels, while AgiBot and Galbot are primarily China-focused. A sales contact or product page does not itself confirm stock, delivery timing or support in a buyer’s region.
Are Chinese humanoid robots as capable as Tesla Optimus or Figure?
Different capabilities at different price points. Chinese robots (Unitree especially) prioritize affordability and availability. Western competitors (Figure, Tesla) prioritize advanced AI and specific industrial capabilities. The “best” depends on whether you value having hardware today at a low price (Chinese advantage) or having frontier AI capabilities in the future (Western advantage, if they deliver).
Why is China ahead on humanoid shipments?
Government backing (funding floor, guaranteed procurement), manufacturing ecosystem speed (Shenzhen), aggressive pricing, and a cultural willingness to ship imperfect hardware and iterate (vs. Western companies that often wait for perfection before shipping).
Is Chinese humanoid robot funding sustainable?
The $9.8B funding vs $4.89B revenue gap suggests the sector is currently investment-driven. This is sustainable as long as government policy support continues and investors maintain confidence. If either wavers, some companies will fail. But the largest players (AgiBot, Unitree, UBTech) have enough backing to survive a correction.
Sources
- Top 10 Humanoid Robot Companies By Shipments Revealed — Forbes (Jan 2026) — 87% Chinese humanoid stat, Omdia rankings
- Omdia Ranks AGIBOT No.1 Worldwide in Humanoid Robot Shipments — PR Newswire (Jan 2026) — AgiBot 5,168 units, 39% global share
- These 10 Chinese Robotics Startups Are Winning The Most VC Funding — Forbes (Apr 2026) — Galbot/AgiBot ~$2B combined, Unitree $246M, ~5,500 units
- Robotics firms secure fresh funding — Global Times (Mar 2026) — Galbot 2.5 billion yuan ($350M) round with national AI fund
- UBTECH Launches UWORLD U1 — PR Newswire (Jul 2026) — UWORLD U1 launch event
- Humanoid Robot Statistics 2026 — Axis Intelligence — $9.8B cumulative VC funding, 288% Q1 2026 growth, $4.89B revenue
- Chinese humanoid startups are rushing to list — CNBC (Jul 2026) — Unitree and LimX IPO-track